Low-cap pot: Small cannabis companies
23 No. of Symbols
−0.080CAD
−14.52 MCAD
5.31 MCAD
147.03 M
About PHARMACIELO LTD
Sector
Industry
CEO
Marc Lustig
Website
Headquarters
Toronto
Founded
2014
ISIN
CA71716K1012
FIGI
BBG00J4XKSR8
PharmaCielo Ltd. operates as a pharmaceutical company. It engages in the processing and supplying all natural, medicinal-grade cannabis oil extracts, and related products to large channel distributors. PharmaCielo's principal and wholly owned subsidiary is PharmaCielo Colombia Holdings S.A.S. The company was founded on July 14, 2014 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where PCLO is featured.
Frequently Asked Questions
The current price of PCLO is 0.20 CAD — it has decreased by 5.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange PHARMACIELO LTD stocks are traded under the ticker PCLO.
PHARMACIELO LTD is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
PCLO earnings for the last quarter are −0.02 CAD whereas the estimation was −0.02 CAD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.01 CAD. See more details about PHARMACIELO LTD earnings.
PHARMACIELO LTD revenue for the last quarter amounts to 2.12 M CAD despite the estimated figure of 4.92 M CAD. In the next quarter revenue is expected to reach 6.85 M CAD.
Yes, you can track PHARMACIELO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, PCLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMACIELO LTD stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMACIELO LTD EBITDA is −8.21 M CAD, and current EBITDA margin is −161.84%. See more stats in PHARMACIELO LTD financial statements.